European Federation of Allergy and Airways Diseases Patients Associations

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1111/all.70182 EAACI Guidelines on the Importance of Green Space in Urban Environments for Allergy and Asthma Prevention
https://doi.org/10.1111/j.1398-9995.2009.02059.x GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma ‘epidemic’
https://doi.org/10.1111/j.1398-9995.2004.00720.x Information provision for allergic consumers – where are we going with food allergen labelling?
https://doi.org/10.1186/s40900-015-0004-9 From tokenism to meaningful engagement: best practices in patient involvement in an EU project
https://doi.org/10.1111/j.1398-9995.2008.01653.x Primary care: the cornerstone of diagnosis of allergic rhinitis
https://doi.org/10.1186/s13601-017-0160-0 Allergen immunotherapy for allergic asthma: a systematic overview of systematic reviews
https://doi.org/10.1111/j.1398-9995.2012.02822.x Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union
https://doi.org/10.1016/s0140-6736(15)60297-5 Rare diseases and effective treatments: are we delivering?
https://doi.org/10.1111/all.13856 Prioritizing research challenges and funding for allergy and asthma and the need for translational research—The European Strategic Forum on Allergic Diseases
https://doi.org/10.1093/ndt/gfw095 Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport Syndrome
https://doi.org/10.1111/j.1398-9995.2006.01106.x Working towards healthy air in dwellings in Europe
https://doi.org/10.1111/j.1398-9995.2008.01944.x Pharmacovigilance of drug allergy and hypersensitivity using the ENDA–DAHD database and the GA2LEN platform. The Galenda project
https://doi.org/10.1186/s12916-017-0856-y Late presentation of chronic viral hepatitis for medical care: a consensus definition
https://doi.org/10.1136/bmj.k4680 Respiratory disease mortality in the United Kingdom compared with EU15+ countries in 1985-2015: observational study
https://doi.org/10.1186/s13601-019-0242-2 Vilnius Declaration on chronic respiratory diseases: multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases
https://doi.org/10.1016/j.leukres.2017.05.019 Living with the burden of relapse in multiple myeloma from the patient and physician perspective
https://doi.org/10.1111/bjd.16093 Towards global consensus on core outcomes for hidradenitis suppurativa research: an update from the HISTORIC consensus meetings I and II
https://doi.org/10.1111/jvh.12493 Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference
https://doi.org/10.3389/fmed.2021.686165 Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative Study
https://doi.org/10.2196/28766 A Road Map for Remote Digital Health Technology for Motor Neuron Disease
https://doi.org/10.1111/all.12258 Improving allergy management in the primary care network - a holistic approach
https://doi.org/10.2217/fon-2017-0715 Insights Into the Hepatocellular Carcinoma Patient Journey: Results of the First Global Quality of Life Survey
https://doi.org/10.1183/23120541.00076-2018 Still Fighting for Breath: a patient survey of the challenges and impact of severe asthma
https://doi.org/10.1016/j.jaip.2020.01.059 Research Priorities in Pediatric Asthma: Results of a Global Survey of Multiple Stakeholder Groups by the Pediatric Asthma in Real Life (PeARL) Think Tank
https://doi.org/10.1111/liv.14282 Securing sustainable funding for viral hepatitis elimination plans
https://doi.org/10.1016/j.jval.2022.03.018 Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force
https://doi.org/10.1007/s40271-018-0325-5 Putting Patients at the Centre of Healthcare: Progress and Challenges for Health Technology Assessments
https://doi.org/10.1111/all.12115 Impact of early diagnosis and control of chronic respiratory diseases on active and healthy ageing
https://doi.org/10.1016/j.dld.2019.11.004 Multidisciplinary management of the nocebo effect in biosimilar-treated IBD patients: Results of a workshop from the NOCE-BIO consensus group
https://doi.org/10.1016/j.jhep.2023.07.029 Uniting to defeat steatotic liver disease: A global mission to promote healthy livers and healthy lives
https://doi.org/10.1080/21678421.2020.1788092 TRICALS: creating a highway toward a cure
https://doi.org/10.1111/hex.13207 Understanding multi‐stakeholder needs, preferences and expectations to define effective practices and processes of patient engagement in medicine development: A mixed‐methods study
https://doi.org/10.1007/s40271-021-00554-8 A Standard Set of Value-Based Patient-Centered Outcomes and Measures of Overall Health in Adults
https://doi.org/10.1186/s13073-016-0376-y Erratum to: Making sense of big data in health research: towards an EU action plan
https://doi.org/10.1186/s13601-020-00321-2 Digital transformation of health and care to sustain Planetary Health: The MASK proof-of-concept for airway diseases—POLLAR symposium under the auspices of Finland’s Presidency of the EU, 2019 and MACVIA-France, Global Alliance against Chronic Respiratory Diseases (GARD, WH0) demonstration project, Reference Site Collaborative Network of the European Innovation Partnership on Active and Healthy Ageing
https://doi.org/10.1111/all.14838 Management of anaphylaxis due to COVID‐19 vaccines in the elderly
https://doi.org/10.1111/jvh.12759 Strategies to manage hepatitis C virus infection disease burden—Volume 4
https://doi.org/10.4193/rhin19.012 Patient Advisory Board for Chronic Rhinosinusitis – A EUFOREA initiative
https://doi.org/10.1186/s12889-022-13724-6 LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries
https://doi.org/10.1111/jdv.19269 First update of the living European guideline (EuroGuiDerm) on atopic eczema
https://doi.org/10.1016/j.drugpo.2017.05.054 Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses
https://doi.org/10.1002/jia2.25052 Hep‐CORE: a cross‐sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017
https://doi.org/10.1186/s40900-023-00430-9 Patients as research partners in preference studies: learnings from IMI-PREFER
https://doi.org/10.1016/j.jhep.2022.08.027 MAFLD 2022: An ELPA/ALPA/EASO-ECPO joint statement on disease stigma
https://doi.org/10.1016/j.lungcan.2022.08.021 Development of an updated, standardized, patient-centered outcome set for lung cancer
https://doi.org/10.1111/liv.15446 Securing wider EU commitment to the elimination of hepatitis C virus
https://doi.org/10.1038/s41591-023-02265-z Screening for fibrosis to diagnose liver diseases early: the LIVERSCREEN project
https://doi.org/10.1017/s0266462323000375 Uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group
https://doi.org/10.1186/s13601-016-0094-y Allergen immunotherapy for allergic asthma: protocol for a systematic review
https://doi.org/10.1016/j.semarthrit.2022.152050 Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: A multinational real-world cohort analysis
https://doi.org/10.3390/jcm9082397 The Hidden Burden of Severe Asthma: From Patient Perspective to New Opportunities for Clinicians
https://doi.org/10.1007/s40629-019-0098-y Atopic eczema score of emotional consequences—a questionnaire to assess emotional consequences of atopic eczema
https://doi.org/10.1183/13993003.02107-2022 Core outcome sets, developed collaboratively with patients, can improve the relevance and comparability of clinical trials
https://doi.org/10.1111/dme.15259 Standardising personalised diabetes care across European health settings: A person‐centred outcome set agreed in a multinational Delphi study
https://doi.org/10.1183/13993003.01231-2022 Identifying and appraising outcome measures for severe asthma: a systematic review
https://doi.org/10.1002/clt2.70002 GA2LEN ANACARE consensus statement: Potential of omalizumab in food allergy management
https://doi.org/10.1080/15412555.2020.1788526 Daily Impact of COPD in Younger and Older Adults: Global Online Survey Results from over 1,300 Patients
https://doi.org/10.1111/cob.12489 The development of a core outcomes set for self‐management interventions for patients living with obesity
https://doi.org/10.1111/all.15857 Addressing adverse synergies between chemical and biological pollutants at schools—The ‘SynAir‐G’ hypothesis
https://doi.org/10.1177/2168479015599810 Innovation of Medical Products: The Evolution of Regulatory Science, Research, and Education
https://doi.org/10.3389/fpubh.2022.842462 Preferences Regarding Self-Management Intervention Outcomes of Dutch Chronically Ill Patients With Limited Health Literacy
https://doi.org/10.1016/j.rmed.2023.107361 EUFOREA pocket guide on the diagnosis and management of asthma: An educational and practical tool for general practitioners, non-respiratory physicians, paramedics and patients
https://doi.org/10.1002/cpt.1121 Medicines Adaptive Pathways to Patients: Why, When, and How to Engage?
https://doi.org/10.1007/s43441-021-00313-9 Optimising Multi-stakeholder Practices in Patient Engagement: A Gap Analysis to Enable Focused Evolution of Patient Engagement in the Development and Lifecycle Management of Medicines
https://doi.org/10.12688/openreseurope.15276.1 Developing the next generation of renewable energy technologies: an overview of low-TRL EU-funded research projects
https://doi.org/10.1371/journal.pgph.0000841 Monitoring progress towards elimination of hepatitis B and C in the EU/EEA
https://doi.org/10.1111/all.15723 Adherence and persistence in allergen immunotherapy (APAIT): A reporting checklist for retrospective studies
https://doi.org/10.1002/clt2.12299 A concept for integrated care pathways for atopic dermatitis—A GA2LEN ADCARE initiative
https://doi.org/10.1007/s12325-023-02724-6 A Patient Charter for Chronic Urticaria
https://doi.org/10.1136/bmjopen-2023-079309 Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial
https://doi.org/10.23736/s2784-8671.24.07664-3 Italian S3-Guideline on the treatment of Atopic Eczema - Part 1: Systemic therapy, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Environmental Dermatology (SIDAPA)
https://doi.org/10.1186/s12961-024-01154-2 Navigating the path towards successful implementation of the EU HTA Regulation: key takeaways from the 2023 Spring Convention of the European Access Academy
https://doi.org/10.1016/j.clml.2022.12.003 Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients
https://doi.org/10.3390/cancers15245764 Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical Trials
https://doi.org/10.1038/s41598-023-49424-3 The preferences of people with amyotrophic lateral sclerosis on riluzole treatment in Europe
https://doi.org/10.1080/14786451.2024.2385632 Enhancing smart readiness of buildings: bridging the knowledge gap to European citizens
https://doi.org/10.1016/j.aohep.2024.101741 A social media listening study of patients’ experiences relating to metabolic dysfunction-associated steatotic liver disease: The LISTEN-MASLD study
https://doi.org/10.1007/978-981-10-4068-9_35 Role of Patient Organisations
https://doi.org/10.4193/rhin24.510 Pocket guide: biologics in upper and lower airways in adults
https://doi.org/10.1038/s41746-025-01697-w Classification grid and evidence matrix for evaluating digital medical devices under the European union landscape
https://doi.org/10.1016/j.clml.2024.04.004 Changes in income and employment after diagnosis among patients with multiple myeloma in The Netherlands
https://doi.org/10.3390/jmahp13020027 Enhancing Patient Engagement in HTA: Using Consensus Research to Overcome PICO Scoping Challenges Under the EU HTAR
https://doi.org/10.1016/j.waojou.2025.101123 Food allergy severity across the world: A World Allergy Organization international survey
https://doi.org/10.1007/s00277-024-06129-5 Patient-reported outcome domains in multiple myeloma randomized controlled trials and association with survival outcomes
https://doi.org/10.3390/jmahp13010006 Avoiding Error and Finding the Right Balance in European Health Technology Assessments: Insights Generated by the European Access Academy
https://doi.org/10.1080/02770903.2025.2466183 Patient perspectives on the use of oral corticosteroids in asthma
https://doi.org/10.1186/s40249-025-01288-7 Best practices for engaging with affected communities: chronic hepatitis B as a case study
https://doi.org/10.2147/por.s487342 Expert Perspectives on Next Generation Health Guidelines: How to Integrate RWE in EBM
https://doi.org/10.1016/j.pec.2025.109363 “About the patient, not for the patient”: A qualitative study on medical reports in hepatology
https://doi.org/10.1016/j.ejca.2025.116064 The use of EORTC QLQ-C30 Summary Score in cancer research and its performance as compared with the EORTC QLQ-C30 Global Health/Quality of Life scale: A systematic review and comparative analysis of effect sizes
https://doi.org/10.3389/falgy.2025.1540499 Raising the bar in respiratory care by EUFOREA: report of the European Union Parliament Symposium, April 2024
https://doi.org/10.2147/copd.s503726 Single-Inhaler Triple Therapy in Primary Care Across Europe: Expert Panel Consensus on the Consequences of Payer-Driven Access Rules and Call to Action
https://doi.org/10.1093/ndt/gfaf161 The unmet need of electrolyte supplements
https://doi.org/10.1007/s13555-025-01587-9 Patient and Caregiver Perceptions on Education and Treatment Needs in Atopic Dermatitis from an International Survey
https://doi.org/10.1186/s12911-025-03229-8 Patients and healthcare professionals’ perspectives on the implementation of shared decision making in multiple myeloma: a multinational qualitative study
https://doi.org/10.1080/21645515.2025.2600657 The Viral Hepatitis Prevention Board (VHPB) supports the continued recommendation for universal hepatitis B vaccination of all newborns within 24 hours of birth
https://doi.org/10.1111/j.1398-9995.2005.00868.x A framework for measuring costs to society of IgE‐mediated food allergy
https://doi.org/10.1111/j.1398-9995.2006.01304.x The limitations of severe asthma: the results of a European survey
https://doi.org/10.1371/journal.pone.0247522 Self-management interventions for adults living with Chronic Obstructive Pulmonary Disease (COPD): The development of a Core Outcome Set for COMPAR-EU project
https://doi.org/10.1182/blood-2019-125749 Real-World (RW) Multiple Myeloma (MM) Patients (Pts) Remain Under-Represented in Clinical Trials Based on Standard Laboratory Parameters and Baseline Characteristics: Analysis of over 3,000 Pts from the Insight MM Global, Prospective, Observational Study